首页> 外文期刊>Expert opinion on therapeutic targets >Therapeutic targets for the treatment of hepatitis E virus infection
【24h】

Therapeutic targets for the treatment of hepatitis E virus infection

机译:治疗戊型肝炎病毒感染的治疗目标

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction: Hepatitis E virus (HEV) is one of the most common causes of acute viral hepatitis in the world with an estimated 20 million infections per year. Although the mortality rate is < 1% among the general population, pregnant women can have a fatality rate of up to 30%. Additionally, chronic hepatitis E has increasingly become a significant clinical problem in immunocompromised individuals. Effective antivirals against HEV are needed.
机译:简介:戊型肝炎病毒(HEV)是世界上急性病毒性肝炎的最常见原因之一,估计每年感染2000万。尽管在一般人群中死亡率不到1%,但孕妇的死亡率可能高达30%。另外,慢性戊型肝炎已逐渐成为免疫功能低下个体的重要临床问题。需要针对HEV的有效抗病毒药。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号